2022
DOI: 10.4236/jtr.2022.103010
|View full text |Cite
|
Sign up to set email alerts
|

Genetic Polymorphisms and Toxicities of First-Line Antituberculosis Drugs: Systematic Review of the Literature

Abstract: Introduction: Polymorphisms are the main genetic factors associated with toxicities of antituberculosis drugs. This literature review summarizes the polymorphisms of the genes that code for the enzymes of the metabolism of antituberculosis drugs and their transmembrane transporters. Some mechanisms of drug-associated toxicities and strategies for their management have also been described in this review. Methods: The bibliographic searches were exclusively carried out in PubMed, over a period of ten years (2010… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 60 publications
(164 reference statements)
0
1
0
Order By: Relevance
“…Tuberculosis (TB) remains a lethal communicable ailment of global public health concern despite the intensified research to understand and eradicate it. [1][2][3] In 2021, about 10.6 million people were estimated to fall ill with TB worldwide with the incident rate rising by 3.6% between 2020 and 2021 with eight countries having two-thirds of the disease's global burden. 4, 5 The emergence of drug resistant TB continues to undermine the gains of global eradication efforts and as such TB has remained a public health scourge.…”
Section: Introductionmentioning
confidence: 99%
“…Tuberculosis (TB) remains a lethal communicable ailment of global public health concern despite the intensified research to understand and eradicate it. [1][2][3] In 2021, about 10.6 million people were estimated to fall ill with TB worldwide with the incident rate rising by 3.6% between 2020 and 2021 with eight countries having two-thirds of the disease's global burden. 4, 5 The emergence of drug resistant TB continues to undermine the gains of global eradication efforts and as such TB has remained a public health scourge.…”
Section: Introductionmentioning
confidence: 99%